No profile data available.
Epigenomics AG N (EPGNF) is a healthcare company in the DNA testing equipment industry, based in Heidelberg, Germany, with about 1 full-time employees.
It reported revenue of 24,000 EUR for fiscal year 2025, and net income of -314,000 EUR. Its market capitalization was $1.00 million as of February 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of February 5, 2026.
Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Heidelberg, Germany.
Epigenomics AG N reported 24,000 EUR in revenue for fiscal year 2025.
$1.00 million as of February 5, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Aspira Women's Health Inc. (AWHL), Co-Diagnostics, Inc. (CODX), Cardio Diagnostics Holdings, Inc. (CDIO), ProPhase Labs, Inc. (PRPH).